Trials / Completed
CompletedNCT06655935
Novel Modified Technique for Transcatheter Closure of Secundum Atrial Septal Defect: A Single Center Experience
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Egyptian Biomedical Research Network · Network
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
Transcatheter closure of secundum atrial septal defects is widely approved worldwide, yet it still has multiple risks like perforation and radiation exposure. In this study, we proposed a modified rapid method for closure of secundum atrial septal defects, to avoid material manipulation inside your heart and decrease complication rate.
Detailed description
Delivery sheath can be advanced over multipurpose catheter instead of stiff wire
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ordinary Transcatheter ASD closure | deploying the Amplatzer delivery system of the Amplatzer™ Septal Occluders ASO inside the left atrial cavity over stiff wire into the pulmonary veins |
| PROCEDURE | modified transcatheter ASD closure | deploying the Amplatzer delivery system of the Amplatzer™ Septal Occluders ASO over the multipurpose catheter inside the left atrial cavity which might help in the shortage of the duration \& the cost of the procedure with less complication rate |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-30
- First posted
- 2024-10-24
- Last updated
- 2024-10-29
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06655935. Inclusion in this directory is not an endorsement.